Works matching IS 03407004 AND DT 2014 AND VI 63 AND IP 4
Results: 9
PD-1 immune cell infiltration inversely correlates with survival of operable breast cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 4, p. 395, doi. 10.1007/s00262-014-1519-x
- By:
- Publication type:
- Article
Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 4, p. 357, doi. 10.1007/s00262-014-1518-y
- By:
- Publication type:
- Article
Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 4, p. 381, doi. 10.1007/s00262-013-1516-5
- By:
- Publication type:
- Article
In vivo immunological antitumor effect of OK-432-stimulated dendritic cell transfer after radiofrequency ablation.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 4, p. 347, doi. 10.1007/s00262-013-1514-7
- By:
- Publication type:
- Article
Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 4, p. 335, doi. 10.1007/s00262-013-1515-6
- By:
- Publication type:
- Article
Self-reactive T cells: suppressing the suppressors.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 4, p. 313, doi. 10.1007/s00262-013-1512-9
- By:
- Publication type:
- Article
A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 4, p. 407, doi. 10.1007/s00262-014-1524-0
- By:
- Publication type:
- Article
Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 4, p. 369, doi. 10.1007/s00262-014-1520-4
- By:
- Publication type:
- Article
Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8 T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 4, p. 321, doi. 10.1007/s00262-013-1510-y
- By:
- Publication type:
- Article